Drugs / rMenB+OMV NZ
last change Jan 2012 re-read 2 minutes ago

rMenB+OMV NZ

Developed for
meningococcal infection
Investigated by
Novartis Vaccines

Trials 1 · a red edge is where a trial was stopped

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01214850 Sep 2010 → Jan 2012 meningococcal infection Novartis Vaccines Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as rMenB+OMV NZ ClinicalTrials.gov intervention name — accepted as the source's own label NCT01214850